Abstract
The antineoplastic drug Docetaxel is a second generation taxane which is used against a great variety of cancers. The drug is highly lipophilic and produces a great array of severe toxic effects that limit its therapeutic effectiveness. The study of the interaction between Docetaxel and membranes is very scarce, however, it is required in order to get clues in relation with its function, mechanism of toxicity and possibilities of new formulations. Using phosphatidylcholine biomimetic membranes, we examine the interaction of Docetaxel with the phospholipid bilayer combining an experimental study, employing a series of biophysical techniques like Differential Scanning Calorimetry, X-Ray Diffraction and Infrared Spectroscopy, and a Molecular Dynamics simulation. Our experimental results indicated that Docetaxel incorporated into DPPC bilayer perturbing the gel to liquid crystalline phase transition and giving rise to immiscibility when the amount of the drug is increased. The drug promotes the gel ripple phase, increasing the bilayer thickness in the fluid phase, and is also able to alter the hydrogen-bonding interactions in the interfacial region of the bilayer producing a dehydration effect. The results from computational simulation agree with the experimental ones and located the Docetaxel molecule forming small clusters in the region of the carbon 8 of the acyl chain palisade overlapping with the carbonyl region of the phospholipid. Our results support the idea that the anticancer drug is embedded into the phospholipid bilayer to a limited amount and produces structural perturbations which might affect the function of the membrane.
Graphical Abstract
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Docetaxel is an anticancer drug which is a member of the second generation of taxanes. The taxanes family embodies Paclitaxel and Docetaxel, Paclitaxel being a diterpenoid natural product extracted from the bark of the Pacific yew (Taxus brevifolia) (Wani et al 1971). Docetaxel (DTX, Fig. 1) is a semi-synthetic analogue of Paclitaxel, prepared from precursor extracted from the needles of Taxus baccata, 10-deacetyl baccatin III (Bissery and Gueritte-Voegelein 1991). DTX differs from Paclitaxel in two positions, it has a hydroxy functionality at C-10 instead of the acetate ester found in Paclitaxel and the bulky phenylpropionate side chain has a tert-butyl substitution attached by means of a carbamate linkage (Clarke and Rivory 1999).
Taxanes are used in the remedy of a wide spectrum of cancers, including refractory ovarian (Adler et al. 1994; Katsumata 2003), breast (Jones et al. 2005; Lyseng-Williamson and Fenton 2005), non-small cell lung (Quiox et al. 2004; He et al. 2015), gastric (Uson Junior et al. 2019) and prostate cancer (Assi et al. 2020). The principal mechanism of action of taxanes underlies in their microtubule stabilizing properties which prevent physiological microtubule depolymerization and disassembly, leading to cell cycle arrest at the G2/M phase and cell death (Tan et al. 2012). Antineoplastic drugs must cross the plasma membrane to elicit pharmacological activity (Bourgaux and Couvreur 2014), consequently, through their biological route the interaction with the membrane becomes unavoidable. The interaction of DTX with the membrane is a complex physical and chemical event, which can affect the rate of penetration of the drug into the cytoplasm where it must reach its specific target. Hence, the interaction of DTX with the membrane should be studied in order to get insight into its mechanism of action.
DTX has been described to originate severe toxic side effects which include neutropenia (de Vries Schultink et al. 2019), musculo skeletal toxicity (Seguin et al. 2017), peripheral neuropathy (Cheng et al. 2021), hypersensitivity reactions (Picard and Castells 2015) and skin toxicity (Arwert 2009). A series of clinical studies have revealed that DTX is more toxic than Paclitaxel. DTX induced the presence of a unique fluid retention syndrome (Rowinsky 1997), it caused more neutropenia, thrombocytopenia, and onycholysis in axillary node-positive early breast cancer patients (Saloustros et al. 2014), shows a tendency towards higher non-haematological toxicities in patients with non-small-cell lung cancer (Esteban et al. 2003), and caused more frequent hematologic and nonhematologic toxicities in metastatic breast cancer patients (Jones et al. 2005). In this regard, DTX-lipids interactions may modify the structure of the membrane, alter its function and also contribute to the mechanism of DTX toxic effects.
In this context, the interaction between taxanes and membrane, and its consequence for its structure and properties, constitutes a considerable field of study. A series of studies have used bilayer model membranes to study the interaction between Paclitaxel and dipalmitoylphosphatidylcholine (DPPC) (Balasubramanian and Straubinger 1994; Zhao et al. 2004), different saturated and unsaturated phosphatidylcholines (Bernsdorff et al. 1999; Zhao and Feng 2004, 2005), using bromoacylated taxanes (Ali et al. 2000), pegylated lipids (Belsito et al. 2005) and in the presence of cholesterol (Zhao et al. 2007). DTX has attained enormous consideration in cancer chemotherapy as a result of its good therapeutic index, exhibiting enhanced efficacy when compared with Paclitaxel (Imran et al. 2020). DTX is more water soluble and promptly absorbed in relation to paclitaxel due to the variation in their chemical structure, showing considerable differences in cytotoxic and antineoplastic actions (da Silva et al. 2018). Despite all the above, studies on the interaction between DTX and phospholipids are very scarce. The interaction between DTX and DPPC has been studied using lipid monolayers at the air–water interface (Fernández-Botello et al. 2008), and the interaction between DTX and dimyristoylphosphatidylcholine has been studied by Differential Scanning Calorimetry (Sarpietro et al. 2013). For the best of our knowledge, the comprehensive study of the interactions between DTX and DPPC bilayers has not been previously carried out.
In this work, we present a combined approach to study DTX interactions with DPPC bilayers, using diverse complementary biophysical techniques, specifically high sensitivity Differential Scanning Calorimetry (DSC), Small and Wide X-ray Diffraction (SAXD and WAXD) and Fourier Transform Infrared Spectroscopy (FTIR), as well as Molecular Dynamics (MD). The central aim of this study is to thoroughly examine and characterize the molecular interactions between DTX and DPPC bilayers in order to obtain information that we believe might contribute to a better understanding of the process of internalization and accumulation inside the target cell affecting the therapeutic efficacy and the mechanism of toxicity of the drug.
Materials and Methods
Materials
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (Dipalmitoylphosphatidylcholine, DPPC, > 99% TLC) was obtained from Avanti Polar Lipids Inc. (Birmingham, AL). Phospholipid concentration was determined by phosphorous analysis (Böttcher et al. 1961). Docetaxel [4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1,7β,10β-trihydroxy-9-oxotax-11-ene13α-yl-(2R,3S)-3-tert-butoxycarbonyl-amino-2-hydroxyphenylpropionate] (DTX, ≥ 98.0%) was obtained from Glentham Life Sciences (UK). Purified water was deionised in a Milli-Q equipment from Millipore (Bedford, MA), and filtered through 0.24 μm filters prior to use. All other reagents were of the highest purity available.
Differential Scanning Calorimetry
The lipid mixtures for DSC measurements were prepared by combination of chloroform solutions containing DPPC and the appropriate amount of DTX as indicated. The organic solvent was evaporated under a stream of dry N2, free of O2, and the last traces of solvent was removed by further 3 h evaporation under high vacuum. To the dry samples, 0.5 ml of a buffer containing 150 mM NaCl, 0.1 mM EDTA, 10 mM Hepes pH 7.4 was added, and biomimetic multilamellar vesicles were formed by vortexing the mixture, at temperature above the gel to liquid-crystalline phase transition temperature of the phospholipid. Experiments were performed using a MicroCal DSC PEAK calorimeter (Malvern Panalytical). The final phospholipid concentration was 1.5 mM, and the heating scan rate was 60 °C h−1. Three consecutive heating scans were carried out for each sample. Thermograms from the second and third scan were identical, the last one being taken for analysis. The integral of heat capacity over temperature gives the calorimetric enthalpy for the transition. Peak areas under the thermograms relative to the baseline was determined as a direct measurement of the enthalpy of the transition. Data were analyzed using ORIGIN software provided by MicroCal. The construction of partial phase diagrams was based on the heating thermograms for a given mixture of phospholipid and drug at various drug concentrations. The onset and completion temperatures for each transition peak were obtained from the heating thermograms taken at the points of intersection of the tangents to the leading edges of the endotherms and the baselines, and were plotted as a function of the molar fraction of drug. These onset and completion temperatures points formed the basis for defining the boundary lines of the partial temperature-composition phase diagram.
X-ray Diffraction
Simultaneous small (SAX) and wide (WAX) angle X-ray diffraction measurements were carried out using a modified Kratky compact camera (MBraum-Graz-Optical Systems, Graz Austria) which employs two coupled linear position sensitive detectors (PSD, MBraum, Garching, Germany). Nickel-filtered Cu Kα X-rays were generated by a Philips PW3830 X-ray Generator operating at 50 kV and 30 mA. Samples for X-ray diffraction were prepared by mixing 10 μmol of DPPC and the appropriate amount of DTX in chloroform, and multilamellar vesicles were formed as described above. After centrifugation at 13,000 rpm, the pellets were placed in a steel holder, which provided good thermal contact to the Peltier heating unit, with cellophane windows. Exposure times were 10 min, allowing 10 min prior to the measurement for temperature equilibration. Background corrected SAXD data were analysed using the program GAP (Global Analysis Program) written by Prof. Georg Pabst (University of Graz, Austria) and obtained from the author (Pabst et al. 2000, 2003). This program allowed to retrieve the membrane thickness, dB = 2(ZH + 2σH) from a full q-range analysis of the SAXD patterns (Pabst 2006). The parameters ZH and σH are the position and width, respectively, of the Gaussian used to describe the electron-dense headgroup regions within the electron density model. The width σH was fixed to 3 Å.
Fourier Transform Infrared Spectroscopy (FTIR)
Samples for the infrared measurements containing 10 μmol of DPPC and the appropriate amount of DTX were formed in 75 μl of the same buffer prepared in D2O as described above. Samples were placed in between two CaF2 windows (25 × 2 mm) separated by 25 μm Teflon spacers and transferred to a Symta cell mount. Infrared spectra were acquired in a Nicolet 6700 FTIR spectrometer (Madison, WI). Each spectrum was obtained by collecting 64 interferograms with a nominal resolution of 2 cm−1. The equipment was continuously purged with dry air in order to minimize the contribution peaks of atmospheric water vapor. The sample holder was thermostatized using a Peltier device (Proteus system from Nicolet). Spectra were collected at 1 °C intervals, allowing 5 min equilibration between temperatures. The D2O buffer spectra taken at the same temperatures were subtracted interactively using either Omnic or Grams (Galactic Industries, Salem, NH) software.
Molecular Dynamics (MD)
The 3D molecular structure of DTX was obtained from the Cambridge Crystallographic Data Centre, CCDC No. 940082 (Cambridge Crystallographic Data Center 2021; Groom et al. 2016). All MD simulations were done using GROMACS 5.0.7 and 2018.1 (Abraham et al. 2015) in the Computational Service of the University of Murcia (Spain). CHARMM36 force field parameters for DPPC, DTX, water, Cl− and Na+ were obtained from CHARMM-GUI (Jo et al. 2000; Brooks et al. 2009; Lee et al. 2016). The membrane bilayer was formed by 2 leaflets oriented normal to the z-axis with a total of 124 molecules of DPPC with and without 12 molecules of DTX in the lipid phase, and a water layer containing a total of 6000 water molecules (TIP3 model), 12 sodium ions, and 12 chloride ions. Three independent simulations were performed using the above molecular distribution of the system. The initial membrane structures were built with the aid of Packmol software (Martínez et al. 2009), where all molecules were randomly distributed in each layer keeping the DPPC molecules oriented normal to z-x, and thus in the different simulations the DTX molecules were at different random starting locations in the lipid phase.
All systems (DPPC and DPPC + DTX) were simulated using the NpT-ensamble at 50 °C. Pressure was controlled semi-isotropically at a pressure of 1 bar and compressibility of 4.5 × 10−5 bar−1. The cutoffs for van der Waals and short-range electrostatic interactions were 1.2 nm, and a force switch function was applied between 1.0 and 1.2 nm (Bjelkmar et al. 2010). Simulations were initiated by an equilibration run for 100 ns, using the V-rescale thermostat and the Berendsen barostat (Berendsen et al. 1984), followed by a production run of 100 ns using the Nose–Hoover thermostat (Hoover 1985) and the Parrinello-Rahman barostat (Parrinello and Rahman 1981). Graphical representations were done with PyMOL 2.3.0 (Schrödinger 2010). Analysis of the trajectories were done over the last 60 ns of the production run trajectories using the Gromacs tools.
Results and Discussion
Differential Scanning Calorimetry (DSC)
We used DSC in order to characterize the influence of DTX on the thermotropic properties of DPPC bilayers and found that the drug perturbed the gel to liquid crystalline phase transition of the phospholipid.
The effect of DTX on the thermotropic phase transition of DPPC is illustrated in Fig. 2. Pure DPPC (Fig. 2A, top thermogram) at low temperature is organized in the lamellar gel phase, Lβ’, where the acyl chains are in the all-trans conformation, fully extended and tilted with respect to the bilayer normal. At 35 °C, the phospholipid undergoes a low enthalpy pretransition which transforms the Lβ’ into the Pβ’ phase in which the bilayer is distorted by a periodic ripple. Around 41 °C the higher enthalpy main phase transition transforms the gel Pβ’ phase into the fluid or liquid crystalline phase, Lα, in which gauche rotational isomerization takes place and the acyl chains are perpendicular to the bilayer plane, in agreement with previous results (Cevc and Marsh 1987; Bourgaux and Couvreur 2014).
As depicted in Fig. 2, the presence of DTX gives rise to an alteration of the thermotropic and structural parameters of DPPC. As presented in Fig. 2A, it seems that the pretransition has already disappeared in the presence of DTX at 0.01 molar fraction, this being in agreement with the report that in dimyristoylphosphatidylcholine system, the pretransition peak disappeared in the presence of DTX 0.015 molar fraction (Sarpietro et al. 2013). However, the enlargement of the 22–37 °C region presented in Fig. 2B shows that at these low concentrations of DTX the pretransition is clearly detected, though broadened and shifted to lower temperatures. Only at DTX 0.04 molar fraction the pretransition could not be detected. This difference could be due either to the high sensitivity calorimeter used in our experiments or to a more pronounced effect of DTX on the shorter homologue dimyristoylphosphatidylcholine.
The presence of increasing concentrations of DTX gradually broadens the main phase transition and produces a displacement to lower temperatures until reaching a DTX 0.08 molar fraction, from which higher concentrations no longer have any additional effect. The width of the transition is an estimation of destabilization of the phospholipids association, related to the size of the cooperative unit and being a measure of the intermolecular interactions between phospholipids molecules (Lewis et al. 2007). The presence of DTX into DPPC bilayers induced a decrease in the cooperativity of the gel to liquid crystalline phase transition. The onset of the main phase transition temperature decreases from 41.2 °C for pure DPPC till 38.9 °C in the presence of DTX 0.08 molar fraction. The changes caused on the main phase transition suggest a localization of DTX in the hydrophobic cooperative region of the bilayer. The enthalpy change of the main phase transition for pure DPPC was found to be of 8.5 kcal mol−1, and it was not substantially altered in the presence of DTX (Fig. 2C). Since the enthalpy change reflects the heat absorbed during the melting of all the phospholipid acyl chains, it suggests that in the presence of DTX all phospholipid molecules in the system still undergo the phase transition.
The phase transition thermograms in the presence of DTX are clearly broadened and asymmetrical and this may reflect a non-uniform DTX distribution in the bilayer. Figure 2D shows that the thermogram of the sample containing DTX 0.08 molar fraction can be fitted to two transition peaks, a broad lower melting peak encompassing 65% of the enthalpy change of the transition, and a sharp higher melting peak encompassing the remaining of the enthalpy change. This behaviour probably reflects the formation of two distinct domains in the bilayer containing different populations of DTX.
The ratios between DTX and phospholipid used in this study are similar to those commonly used in previous studies on the interaction between taxanes and membranes. The correlation between these ratios and the concentrations of DTX exhibiting anticancer activity is not direct, but an approximation can be made. It has been reported for an epithelial cell line that the phospholipid content is around 2 μg Pi/106 cells (Casali et al. 2013). Assuming that the phospholipid content in other cancer cell lines is similar to that value and considering that concentration of DTX usually range between 10 and 120 nM, it renders that under a cell culture condition such as 4 × 104 cells and a volume of the medium of 0.1 ml (Trebunova et al., 2012) the DTX/phospholipid ratio in physiological studies might reach a value from 0.01 to 0.10 which is very close to the values used in our study. In addition, we would like to point out that the molar ratios studied in our model system are not necessarily required to be homogeneous in the whole cellular membrane, it would be enough that this DTX/phospholipid ratio be attained locally in certain parts of the membrane.
In the following studies, a DTX concentration of 0.08 molar fraction was selected in order to study the maximal action of the drug on the properties of DPPC bilayers both below and above the main phase transition temperature.
X-ray Diffraction
We have used Small and Wide Angle X-Ray Diffraction (SAXD and WAXD) respectively to obtain information regarding the structural properties and packing characteristics of the DPPC-DTX system and found that the presence of DTX promoted the ripple gel phase and increased the bilayer thickness in the liquid crystalline phase. The multilamellar organization of phospholipids generates a SAXD pattern with reflections distances relating as 1:1/2:1/3:1/4…, the largest first order reflection correlating with the interlamellar repeat distance (d) which includes the bilayer thickness and the thickness of the water layer between bilayers (Luzzati 1968; Tyler et al. 2015).
Pure DPPC shows SAXD bilayers reflections with a d value of 62.5 Å at 30 °C, 70 Å at 38 °C, and 64.6 Å at 45 °C (Fig. 3A top). DPPC WAXS reflections are presented in Fig. 3B (top). At 30 °C the pattern shows a sharp reflection centred at 4.21 Å and a broad reflection at 4.10 Å which correlate with the quasi hexagonal lattice in which the acyl chains are tilted with respect to the bilayer normal forming one group of four closely spaced chains with two chains at a slightly larger separation characteristic of the Lβ’ gel phase (Tardieu et al. 1973). At 38 °C, a single reflection is present at 4.20 Å attributed to a lipid phase with hydrocarbon chains being oriented normal to the bilayer plane in a two-dimensional hexagonal lattice as defined for the Pβ’ gel phase (Lohner et al. 2001). At 45 °C, the WAXD pattern consists of a single broad diffuse reflection characteristic of the Lα liquid crystalline phase (Kriechbaum and Laggner 1996). All the aforementioned data reflect the DPPC successive transitions form the tilted gel phase to the ripple gel phase and then to the fluid phase and are in agreement with previous reports (Carion-Taravella et al. 2002; Berényi et al. 2013).
The SAXD patterns in the presence of DTX 0.08 molar fraction (Fig. 3A bottom) always show two reflections related as 1:1/2 indicating that the presence of the drug does not modify the lamellar structural assembly of DPPC. At 30 °C the d value for the mixture DPPC-DTX is considerably larger (70.6 Å) than that of the pure phospholipid (62.5 Å), and the WAXD pattern for the mixture only shows a single reflection at 4.16 Å. This WAXD reflection is broader than the corresponding reflection of conventional Lβ phases formed in other phospholipid systems like phosphatidylethanolamine (Ortiz et al. 2008) revealing the tilt of the chains in the Pβ’ phase, and indicating that, at this temperature, the presence of DTX promotes the organization of the ripple gel phase. At 38 °C the system is still organized in the ripple phase. At 45 °C, the diffuse scattering reflection indicate that the mixture is organized in the liquid crystalline phase, however, the d value in the presence of DTX is larger (66.3 Å) than that of the pure phospholipid (64.6 Å).
In order to discern whether this difference in interlamellar repeat distance was due to a change in the bilayer thickness of to a change in the thickness of the water layer, background subtracted SAXD patterns for pure DPPC and DPPC containing DTX 0.08 molar fraction at 45 °C were examined using the GAP program (Fig. 3A solid lines). Figure 4 shows the correspondent one-dimensional electron density profiles along the bilayer normal calculated from the SAXD diffraction patterns. The profile for pure DPPC consists of a central region of comparatively low electron density values which correspond to the hydrocarbon chains of the phospholipid molecules; a region of relatively high electron density corresponding to the headgroups, which symmetrically border the hydrocarbon region; and an interstitial solvent-rich layer with electron density values intermediate between those of the first two regions. The bilayer is centred at the origin, so that the low electron density trough at 0 Å corresponds to the terminal methyl groups in the bilayer centre. For pure DPPC in the fluid phase we determined a bilayer thickness, dB, of 42.3 ± 0.2 Å, the presence of DTX increased the bilayer thickness to a value of 46.4 ± 0.2 Å (p = 0.003, p < 0.05, n = 3).
A partial phase diagram for the DPPC component in mixtures with DTX has been composed using the phase transition temperatures from the DSC data and the structural characterization from the X-ray diffraction experiments, and is presented in Fig. 5. The solidus and fluidus lines display a near ideal behaviour, their temperatures decreasing with increasing concentrations of DTX, this decrease is less marked in the case of the fluidus line. Until a DTX concentration of 0.08 molar fraction, the system evolves from a gel phase (G) to a liquid crystalline phase (Fluid, F) through a coexistence region which is wider as more DTX is present. However, at concentrations of DTX higher than 0.08 molar fraction, the system behaves differently, both the solidus an fluidus lines keep horizontal, or even increase slightly their temperature, as more DTX is present in the system. The evidence that the main phase transition is not further perturbed when DTX is present at concentration higher than 0.08 molar fraction indicates the existence of immiscibility both in the gel and in the fluid phase. This phase separation may reveal an extensive aggregation of DTX inside the bilayer, but given the high molecular mass of DTX it probably reflects a limited solubility of DTX in the DPPC bilayer as shown previously for Paclitaxel (Balasubramanian and Straubinger 1994). Studies on the interaction of Paclitaxel with DPPC showed a qualitative similar behaviour with a maximum incorporation between 3% (Balasubramanian and Straubinger 1994; Belsito et al. 2005) and 5% (Bernsdorff et al. 1999; Ali et al. 2000; Zhao et al. 2004; Zhao et al. 2007). From a quantitative point of view DTX seems to better incorporate into DPPC bilayer, and this might enhance the accumulation of DTX in the target cell and contribute to the better efficacy that has been reported for the drug (Imran et al. 2020).
Infrared Spectroscopy
To investigate the effect of DTX on the hydrophobic and interfacial parts of the DPPC molecule, infrared spectroscopy was used and we found that the drug altered the lipid–water hydrogen bonding. Figure 6 shows the temperature dependence of the frequency at the absorbance maximum of the symmetric methylene stretching vibration band, sν (CH2), of the infrared spectra of pure DPPC and that of the system containing DTX 0.08 molar fraction. The inset of Fig. 6 shows the 3000–2800 cm−1 spectral region containing the absorption bands originating from the different carbon-hydrogen stretching vibrations of DPPC molecule at temperatures below and above the main gel to liquid crystalline phase transition, the arrow points to the methylene symmetric stretching band. This band is of special importance because, being free of overlapping contributions from other groups, is susceptible to changes in the mobility and conformational disorder of the phospholipid acyl chains (Lewis and McElhaney 2006). For pure DPPC in the gel tilted phase the absorption maximum of the band is detected close to 2848.7 cm−1, this value increases slightly to 2849 cm−1 in the rippled gel phase, and then raises abruptly during the main phase transition reaching wavenumbers close to 2851 cm−1 at 50 °C. This rise in frequency, which appears with a broadening of the absorption band (see inset of Fig. 5), is indicative of the gel to liquid crystalline phase transition of hydrated phospholipids and come from the expanded conformational disorganization in the phospholipid acyl chains that takes place at the phase transition (increase in the gauche/trans conformer ratio) (Mantsch and McElhaney 1991). In the system containing DTX, the drug makes the small increase occurring at the pretransition to vanish and generates a broadening of the transition which is relocated to lower temperature values in consonance with the DSC experiments presented above. The increase in wavenumber taking place at the main phase transition both in pure DPPC and in the presence of DTX is identical (approx. 2 cm−1) and this agrees with the evidence from DSC that the enthalpy change for the phase transition is not altered in the presence of the drug.
It has been reported that incorporation of 10 mol% Paclitaxel produced a very small increase of the wavenumber of the maximum of this band both in the gel and the liquid crystalline phase of DPPC, and contrary to that, the presence of Paclitaxel in dimirystoylphosphatidylserine systems induced a slight decrease of the wavenumber in both phases (Bernsdorff et al. 1999). Studies on the effect of Paclitaxel on the fluidity of phospholipid bilayers using steady-state anisotropy produced also differing results, while Paclitaxel produced a fluidizing effect in the gel phase and had no effect in the liquid crystalline phase of DPPC (Balasubramanian and Straubinger 1994), a slight rigidification effect was reported in unsaturated phosphatidylcholines (Bernsdorff et al. 1999). In our case for DTX, as observed in Fig. 6, the change in gauche/trans conformer ratio both in the gel and the liquid crystalline phase are not substantial, the slight effects of the drug being within the experimental error.
Interestingly, the presence of DTX originates striking changes in the ester carbonyl stretching band, ν(C = O), of the infrared spectra of DPPC which appears near 1730 cm−1. The ν(C = O) region of the spectra of phospholipids incorporates clues about phospholipid interfacial hydration and hydrogen bonding interplay, and hence supply specifics about the intermolecular interactions that take place in this region. As seen in Fig. 7AB, the ν(C = O) band of DPPC is a rather broad one over 1760–1680 cm−1, in accordance with previous reports (Mantsch and McElhaney 1991). It is accepted that this band is an addition of two subcomponents bands, one located near 1742 cm−1 reflecting a subpopulation of non-hydrogen bonded carbonyl groups and another one located near 1728 cm−1 reflecting a subpopulation of hydrogen bonded carbonyl groups (Lewis et al. 1994).
Pure DPPC exhibits band maxima near 1733.6 cm−1 in the gel phase (Fig. 7A) and near 1731.6 cm−1 in the liquid crystalline phase (Fig. 7B) in agreement with previous report (Chicano et al. 2001). This variation in the frequency maxima to lower values reflects the increment in band intensity of the subjacent subcomponent band near 1728 cm−1 which is associated to a greater extent of hydrogen bonded carbonyl groups originating from the increase in the hydration of the polar-nonpolar interface induced during the phase transition to the liquid crystalline state (Zhang et al. 1997). In the presence of DTX the maxima of the carbonyl band appear at higher frequencies than that of the pure DPPC, in the gel phase (Fig. 7C) the maximum is located near 1735.1 cm−1 and in the liquid crystalline phase (Fig. 7D) is located near 1734.3 cm−1. The displacement of the carbonyl band maxima to higher wavelength suggests that there would be a major contribution of the subpopulation of non-hydrogen bonded carbonyl group and hence a higher degree of dehydration of the lipid polar-nonpolar interface in the presence of the drug.
To assess the possibility that the presence of DTX would produce a less hydrogen bonded interfacial region of DPPC bilayers, the different ester carbonyl stretching spectra were submitted to curve fitting through simulation by a Gaussian–Lorenztian function, and the results are presented also in Fig. 7. In agreement with previous reports (Lewis et al. 1994, 1996), the spectra corresponding to pure DPPC were best fitted to two component: a narrower component at 1741 cm−1 and a broader one at 1728 cm−1, as commented above. In the system containing DTX no good fit to two components could be obtained. It has been reported that DTX exhibits carbonyl absorption maximum near 1711 cm−1 (Fang et al. 2015; Albano et al. 2019; Jose et al. 2019). Even though the presence of DTX in our samples is low (0.08 molar fraction) the number of carbonyl groups in the DTX molecule makes their contribution significant. We found that the band profile could be fitted to a composite of three components with maxima near 1742, 1728 and 1711 cm−1, and we assigned the lower wavelength carbonyl component to the absorption of DTX carbonyl. The simulated components were analysed and their relative areas were calculated.
Table 1 displays an overview of the temperature dependent variation in the band contribution of the two ester carbonyl stretching components of DPPC displayed by pure DPPC and DPPC containing DTX, omitting the contribution of the DTX carbonyl component at 1711 cm−1. In the case of pure DPPC, in close accordance with previous results (Mannock et al. 2008; Silva et al. 2011), we found that the contribution of the non-hydrogen bonded carbonyl component is around 25% and 19% in the gel phase and the liquid crystalline phase respectively. The presence of DTX is associated with an increase in the relative area of the component band located near 1742 cm−1 corresponding to non-hydrogen bonded carbonyls groups. In the gel phase the contribution of this component increases from 25% for pure DPPC to 29.5% in the presence of DTX, however, in the liquid crystalline phase this increase is much larger changing from 19% for pure DPPC to 33.3% in the presence of drug. These findings are especially noteworthy because they indicate that the presence of DTX generate not only a change in the hydrogen-bonding interactions in the interfacial region of the bilayer, but also a dehydration effect which is more noticeable in the liquid crystalline phase.
Molecular Dynamics
Computer simulation, such as MD, has proven to be an important contribution to biophysical research on the physicochemical properties of lipid membranes, as it provides atomic detail of the simulated system (Friedman et al. 2018). The area per lipid at the membrane aqueous interface is frequently used as a property of the lipid bilayer for validating MD simulations and as a proof of convergence (Venable et al. 2019). Figure 8 shows the progression of the area per lipid of the simulation runs, where it can be observed that the area per lipid reach convergence and keeps constant in the time range used for all the analysis (last 60 ns). The area per lipid is calculated from the lateral dimensions of the simulation box (the area of the x y plane) divided by the number of lipids in each leaflet. In our simulation the area per lipid of pure DPPC bilayer above the phase transition (50 °C) was calculated to be 60 ± 0.7 Å2, this value is among reported data for this phospholipid membrane (Schindler and Seelig 1975; Nagle 1993; Kučerka et al. 2008). The presence of DTX in the DPPC membrane did not significantly alter the area per lipid [60 ± 1.0 Å2, p = 0.59 (p > 0.05)].
Membrane thickness has been calculated from the distance between the averaged z-positions of the phosphorus atoms of opposing leaflets. For a pure DPPC membrane, we obtained a distance of 39.5 ± 1.3 Å, which is well among previously reported data (Nagle and Tristan-Nagle 2000; Kučerka et al. 2011). In the presence of DTX we found a significant increase in the membrane thickness to 46.7 ± 0.9 Å, p = 0.0012 (p < 0.05). These results are in line with the calculated dB values from our diffraction X-ray experiments (Fig. 4). It has been proposed that integral membrane proteins have hydrophobic parts that are in contact with the phospholipid acyl chains and are essential for balanced integration of the protein into the bilayer (Killian 1998). Hydrophobic mismatch takes place when the hydrophobic length of the integral protein does not match the hydrophobic thickness of the membrane, this alteration of the membrane properties could be responsible for lipid-dependent protein function as it could produce some alteration in the structure of the protein (Cybulski and de Mendoza 2011). Taking into account that integral membrane proteins are responsible for important cellular processes, the increase in the bilayer thickness exerted by DTX might be important when considering the hydrophobic mismatch and may have a potential in the mechanism of action of some of the toxic effect of the drug.
The criteria adopted to assume hydrogen bonds formation was that the distance between the water hydrogen and the DPPC oxygen be shorter than or equal to 3.5 Å and the H-bond angle less than or equal to 30°. For pure DPPC, we obtained a result of 1.48 ± 0.02 hydrogen bonds from water to the carbonyl oxygen atoms of DPPC per phospholipid molecule, which is within reported values which range from 1.2 to 2.18 (Pasenkiewicz-Gierula et al. 1997; Leekumjorn and Sum 2006; Elola and Rodriguez 2018). The presence of DTX in the membrane decreases the hydrogen bonds number to 1.36 ± 0.01, p = 0.0013 (p < 0.05), which is consistent with the dehydration observed in the carbonyl group by IR spectroscopy (Table 1).
We found a value of 0.47 ± 0.03 hydrogen bonds from water to carbonyl oxygen atoms of DTX per phospholipid molecule. The presence of an additional low frequency phospholipid carbonyl component has been reported for saturated 1,2-diacylphosphatidylethanolamines (Lewis and McElhaney 1993), acyl–alkyl analogues of phosphatidylcholines (Lewis et al. 1994, 1996), and also for mixtures of DPPC and highly lipophilic compounds (Jiménez et al. 2002). However, in our case we found that the formation of hydrogen bonds between the carbonyl of DPPC and other groups different from water (for example with DTX) were very minor. The latter suggest that the lower wavelength carbonyl component indeed corresponded to the carbonyl of DTX and suggest that the establishment of hydrogen bonds between DTX carbonyls and water contributes to the decreased number of bonds between DPPC carbonyls and water, as found in our FTIR measurements.
The mass density of the simulated membranes at 50 °C is shown in Fig. 9A. Some important positions of the DPPC molecule along z-axis have been included: the terminal methyl groups to show the center of the membrane (C16 atoms), the center of the hydrocarbon chains of DPPC (C8 atoms), the carbonyl groups (C1 atoms), and the polar head region (P atoms). It can be seen that DTX molecules are located in the hydrophobic core of the membrane, being centered at about the C8 atoms of the hydrocarbon chains of DPPC, the center of the hydrophobic core of a monolayer. However, DTX band overlaps well with the carbonyl groups and even reaches the P atoms band in the polar head group region.
Figure 9B shows a snapshot of the simulation box at 50 °C of DPPC/DTX mixture where the location of DTX in the bilayer can be observed. This is the expected location for DTX considering the experimental results commented above, the location near C8 atom allows DTX to perturb the gel to liquid crystalline phase transition and the proximity to the carbonyl region do DPPC enable the drug to interfere with the hydrogen bonding pattern of the interfacial region of the bilayer.
The tendency of DTX to aggregate in the membrane has been determined by calculating the frequency of formation of different size of DTX clusters within a cutoff distance of 3 Å (Fig. 10). Most of the DTX molecules are found in the DPPC membrane in clusters of two molecules, although bigger cluster sizes of 3 and 4 molecules can also be observed, thus it can be concluded that most of DTX molecules are forming aggregates in the membrane. The presence of these different populations of DTX in the fluid bilayer may explain the appearance of two different domains which are responsible for the two slightly separate transitions which conformed the thermogram in the presence of the drug (Fig. 2D); the presence of clusters may also justify the modest decrease in temperature of the fluidus line in comparison with the solidus line when the concentration of DTX is increased (Fig. 5).
Conclusions
Molecular interactions between DTX and DPPC were investigated with biomimetic bilayer membranes using a combined experimental and computational approach. DSC studies have shown that DTX is miscible with the phospholipid bilayer only to a limited extent, perturbing the pretransition and the main gel to liquid crystalline phase transition, broadening and shifting the transition temperature to lower values, and giving rise to immiscible phase separation when the presence of the drug is higher than 0.08 molar fraction. Analysis using X-Ray Diffraction revealed that the drug promotes the formation of the ripple phase in the gel state and increased the bilayer thickness in the liquid crystalline phase. FTIR experiments illustrated how the decrease in the transition temperature could be followed through the change in gauche conformers of the methylene chains of the phospholipid, and established the alteration in the hydrogen-bonding interactions produced by DTX on the interfacial region of the bilayer conducing to a dehydration of the region. The experimental conclusions supported the results of Molecular Dynamics were an increase in the bilayer thickness and a dehydration effect were also postulated. Simulation experiments located the anticancer molecule forming small clusters in the region of the carbon 8 of the phospholipid acyl chain palisade overlapping with the interfacial carbonyl region in agreement with the effect observed by experimental techniques. We believe that the observed interactions between DTX and DPPC generate physical disturbances which could alter membrane function, and may help to discern the mechanism of action of the increasing list of biological action of DTX.
Data availability
Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
References
Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B, Lindahl E (2015) Gromacs: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. Softw X 1–2:19–25. https://doi.org/10.1016/j.softx.2015.06.001
Adler LM, Herzog TJ, Williams S, Rader JS, Mutch DF (1994) Analysis of exposure times and dose escalation of paclitaxel in ovarian cancer cell lines. Cancer 74:1891–1898. https://doi.org/10.1002/1097-0142(19941001)74:7%3C1891::aid-cncr2820740711%3E3.0.co;2-k
Albano JMR, Ribeiro LNdM, Couto VM, Barbosa Messias M et al (2019) Rational design of polymer-lipid nanoparticles for docetaxel delivery. Colloids Surf, B 175:56–64. https://doi.org/10.1016/j.colsurfb.2018.11.077
Ali S, Minchey S, Janoff A, Mayhew E (2000) A differential scanning calorimetry study of phosphocholines mixed with paclitaxel and its bromoacylated taxanes. Biophys J 78:246–256. https://doi.org/10.1016/S0006-3495(00)76588-X
Arwert L (2009) Docetaxel-induced skin toxicity. Neth J Med 67:33–34
Assi T, Rassy E, Farhat F, Kattan C, Kattan J (2020) Docetaxel rechallenge in patients with metastatic prostate cancer: a comprehensive review. Oncol Res Treat 43:299–306. https://doi.org/10.1159/000506693
Balasubramanian SV, Straubinger RM (1994) Taxol-lipid interactions: taxol-dependent effects on the physical properties of model membranes. Biochemistry 33:8941–8947. https://doi.org/10.1021/bi00196a011
Belsito S, Bartucci R, Sportelli L (2005) Paclitaxel interaction with phospholipid bilayers: high-sensitivity differential scanning calorimetric study. Thermochim Acta 427:175–180. https://doi.org/10.1016/j.tca.2004.09.009
Berendsen HJC, Postma JPM, Van Gunsteren WF, Dinola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684–3690. https://doi.org/10.1063/1.448118
Berényi S, Mihály J, Kristyán S, Naszályi Nagy L, Telegdi J, Bóta A (2013) Thermotropic and structural effects of poly (malic acid) on fully hydrated multilamellar DPPC-water systems. Biochim Biophys Acta—Biomembr 1828:661–669. https://doi.org/10.1016/j.bbamem.2012.09.023
Bernsdorff C, Reszka R, Winter R (1999) Interaction of the anticancer agent taxol (TM) (paclitaxel) with phospholipid bilayers. J Biomed Mater Res 46:141–149. https://doi.org/10.1002/(SICI)1097-4636(199908)46:2%3c141::AID-JBM2%3e3.0.CO;2-U
Bissery MC, Gueritte-Voegelein F (1991) Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue. Cancer Res 51:4845–4852
Bjelkmar P, Larsson P, Cuendet MA, Hess B, Lindah l E, (2010) Implementation of the charmm force field in GROMACS: analysis of protein stability effects from correction maps, virtual interaction sites, and water models. J Chem Theory Comput 6:459–466. https://doi.org/10.1021/ct900549r
Böttcher C, Gent C, Pries C (1961) A rapid and sensitive sub-micro phosphorus determination. Anal Chim Acta 24:203–204
Bourgaux C, Couvreur P (2014) Interactions of anticancer drugs with biomembranes: what can we learn from model membranes? J Control Release 190:127–138. https://doi.org/10.1016/j.jconrel.2014.05.012
Brooks BR, Brooks CL, Mackerell AD, Nilsson L, Petrella RJ, Roux B et al (2009) CHARMM: the biomolecular simulation program. J Comput Chem 30:1545–1614. https://doi.org/10.1002/jcc.21287
Cambridge Crystallographic Data Center (2021) CSD web interface—intuitive, cross-platform, web-based access to CSD data [Internet]. Available from: https://www.ccdc.cam.ac.uk
Carion-Taravella B, Lesieur S, Chopineau J, Lesieur P, Ollivon M (2002) Phase behavior of mixed aqueous dispersions of dipalmitoylphosphatidylcholine and dodecyl glycosides: a differential scanning calorimetry and X-ray diffraction investigation. Langmuir 18:325–335. https://doi.org/10.1021/la001638r
Casali CI, Weber K, Favale NO, Fernández Tome MC (2013) Environmental hyperosmolality regulates phospholipid biosynthesis in the renal epithelial cell line MDCK. J Lipid Res 54:677–691. https://doi.org/10.1194/jlr.M031500
Cevc G, Marsh D (1987) Phospholipid bilayers physical principles and models. Wiley, New York. https://doi.org/10.1002/cbf.290060221
Cheng HL, Molassiotis A, Leung AKT, Wong KH (2021) Docetaxel-induced peripheral neuropathy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy. Breast Care 16:269–275. https://doi.org/10.1159/000507843
Chicano JJ, Ortiz A, Teruel JA, Aranda FJ (2001) Organotin compounds alter the physical organization of phosphatidylcholine membranes. Biochim Biophys Acta—Biomembr 1510:330–341. https://doi.org/10.1016/S0005-2736(00)00365-5
Clarke SJ, Rivory LP (1999) Clinical pharmacokinetics of docetaxel. Clin Pharmacokinet 36:99–114. https://doi.org/10.2165/00003088-199936020-00002
Cybulski LE, de Mendoza D (2011) Bilayer hydrophobic thickness and integral membrane protein function. Curr Protein Pept Sci 12:760–766. https://doi.org/10.2174/138920311798841681
da Silva GH, Fernandes MA, Trevizan LNF, de Lima FT, Eloy JO, Chorilli M (2018) A critical review of properties and analytical methods for the determination of docetaxel in biological and pharmaceutical matrices. Crit Rev Anal Chem 48:517–527. https://doi.org/10.1080/10408347.2018.1456315
de Vries Schultink AHM, Crombag MRBS, van Werkhoven E, Otten HM, Bergman AM, Schellens JHM, Huitema ADR, Beijnen JH (2019) Neutropenia and docetaxel exposure in metastatic castration-resistant prostate cancer patients: a meta-analysis and evaluation of a clinical cohort. Cancer Med 8:1406–1415. https://doi.org/10.1002/cam4.2003
Elola MD, Rodriguez J (2018) Influence of cholesterol on the dynamics of hydration in phospholipid bilayers. J Phys Chem B 122:5897–5907. https://doi.org/10.1021/acs.jpcb.8b00360
Esteban E, González de Sande L, Fernández Y et al (2003) Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy. Ann Oncol 14:1640–1647. https://doi.org/10.1093/annonc/mdg456
Fang G, Tang B, Chao Y, Zhang Y, Xu H, Tang X (2015) Improved oral bioavailability of docetaxel by nanostructured lipid carriers: in vitro characteristics, in vivo evaluation and intestinal transport studies. RSC Adv 5:96437–96447. https://doi.org/10.1039/c5ra14588k
Fernández-Botello A, Comelles F, Alsina MA, Cea P, Reig F (2008) A monolayer study on interactions of docetaxel with model lipid membranes. J Phys Chem B 112:13834–13841. https://doi.org/10.1021/jp806423k
Friedman R, Khalid S, Aponte-Santamaría C, Arutyunova E et al (2018) Understanding conformational dynamics of complex lipid mixtures relevant to biology. J Membr Biol 251:609–631. https://doi.org/10.1007/s00232-018-0050-y
Groom CR, Bruno IJ, Lightfoot MP, Ward SC (2016) The Cambridge structural database. Acta Crystallogr Sect B Struct Sci Cryst Eng Mater 72:171–179. https://doi.org/10.1107/S2052520616003954
He X, Wang J, Li Y (2015) Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of phase iii randomized controlled trials. Onco Targets Ther 8:2023–2031. https://doi.org/10.2147/OTT.S85648
Hoover WG (1985) Canonical dynamics: equilibrium phase-space distributions. Phys Rev A 31:1695–1697. https://doi.org/10.1103/physreva.31.1695
Imran M, Saleem S, Chaudhuri A, Ali J, Baboota S (2020) Docetaxel: an update on its molecular mechanisms, therapeutic trajectory and nanotechnology in the treatment of breast, lung and prostate cancer. J Drug Deliv Sci Technol 60:101959. https://doi.org/10.1016/j.jddst.2020.101959
Jiménez M, Aranda FJ, Teruel JA, Ortiz A (2002) The chemical toxic benzo[a]pyrene perturbs the physical organization of phosphatidylcholine membranes. Environ Toxicol Chem 21:787–793. https://doi.org/10.1002/etc.5620210415
Jo S, Kim T, Iyer VG, Im W (2000) CHARMM-GUI: a web-based graphical user interface for CHARMM. J Comput Chem 1469:159–195. https://doi.org/10.1002/jcc.20945
Jones SE, Erban J, Overmoyer B et al (2005) Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol 23:5542–5551. https://doi.org/10.1200/JCO.2005.02.027
Jose S, Cinus TA, Sebastian R, Shoja MH et al (2019) Transferrin-conjugated docetaxel-PLGA nanoparticles for tumor targeting: influence on MCF-7 cell cycle. Polymers 11:1–5. https://doi.org/10.3390/polym11111905
Katsumata N (2003) Docetaxel: an alternative taxane in ovarian cancer. Br J Cancer 89(SUPPL. 3):S9–S15. https://doi.org/10.1038/sj.bjc.6601495
Killian JA (1998) Hydrophobic mismatch between proteins and lipids in membranes. Biochim Biophys Acta—Rev Biomembr 1376:401–416. https://doi.org/10.1016/S0304-4157(98)00017-3
Kriechbaum M, Laggner P (1996) States of phase transitions in biological structures. Prog Surf Sci 51:233–261. https://doi.org/10.1016/0079-6816(96)00003-2
Kučerka N, Nagle JF, Sachs JN, Feller SE, Pencer J, Jackson A, Katsaras J (2008) Lipid bilayer structure determined by the simultaneous analysis of neutron and X-ray scattering data. Biophys J 95:2356–2367. https://doi.org/10.1529/biophysj.108.132662
Kučerka N, Nieh MP, Katsaras J (2011) Fluid phase lipid areas and bilayer thicknesses of commonly used phosphatidylcholines as a function of temperature. Biochim Biophys Acta—Biomembr 1808:2761–2771. https://doi.org/10.1016/j.bbamem.2011.07.022
Lee J, Cheng X, Swails JM, Yeom MS, Eastman PK, Lemkul JA et al (2016) CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J Chem Theory Comput 12:405–413. https://doi.org/10.1021/acs.jctc.5b00935
Leekumjorn S, Sum AK (2006) Molecular simulation study of structural and dynamic properties of mixed DPPC/DPPE bilayers. Biophys J 90:3951–3965. https://doi.org/10.1529/biophysj.105.076596
Lewis RNAH, McElhaney RN (1993) Calorimetric and spectroscopic studies of the polymorphic phase behavior of a homologous series of n-saturated 1,2-diacyl phosphatidylethanolamines. Biophys J 64:1081–1096. https://doi.org/10.1016/S0006-3495(93)81474-7
Lewis RNAH, McElhaney RN, Pohle W, Mantsch HH (1994) Components of the carbonyl stretching band in the infrared spectra of hydrated 1,2-diacylglycerolipid bilayers: a reevaluation. Biophys J 67:2367–2375. https://doi.org/10.1016/S0006-3495(94)80723-4
Lewis RNAH, Pohle W, McElhaney RN (1996) The interfacial structure of phospholipid bilayers: differential scanning calorimetry and fourier transform infrared spectroscopic studies of 1,2-dipalmitoyl-sn-glycero-3-phosphorylcholine and its dialkyl and acyl-alkyl analogs. Biophys J 70:2736–2746. https://doi.org/10.1016/S0006-3495(96)79843-0
Lewis RNAH, McElhaney RN (2006) Vibrational spectroscopy of lipids. In: Chalmers JM, Griffiths PR (eds) Handbook of vibrational spectroscopy. Wiley, Chichester, pp 3447–3464. https://doi.org/10.1002/0470027320.s8203
Lewis RNAH, Mannock DA, McElhaney RN (2007) Differential scanning calorimetry in the study of lipid phase transitions in model and biological membranes. In: Dopico AM (ed) Methods in membrane lipids. Methods in molecular biology, vol 400. Humana Press, Totowa. https://doi.org/10.1007/978-1-59745-519-0_12
Lohner K, Latal A, Degovics G, Garidel P (2001) Packing characteristics of a model system mimicking cytoplasmic bacterial membranes. Chem Phys Lipids 111:177–192. https://doi.org/10.1016/S0009-3084(01)00157-8
Luzzati V (1968) X-ray diffraction studies of lipid–water systems. In: Chapman D (ed) Biological membranes. Academic Press, New York, pp 71–123
Lyseng-Williamson KA, Fenton C (2005) Docetaxel: a review of its use in metastatic breast cancer. Drug 65:2513–2531. https://doi.org/10.2165/00003495-200565170-00007
Mannock DA, Lee MYT, Lewis RNAH, McElhaney RN (2008) Comparative calorimetric and spectroscopic studies of the effects of cholesterol and epicholesterol on the thermotropic phase behaviour of dipalmitoylphosphatidylcholine bilayer membranes. Biochim Biophys Acta—Biomembr 1778:2191–2202. https://doi.org/10.1016/j.bbamem.2008.05.004
Mantsch HH, McElhaney RN (1991) Phospholipid phase transitions in model and biological membranes as studied by infrared spectroscopy. Chem Phys Lipids 5(213):226. https://doi.org/10.1016/0009-3084(91)90077-O
Martínez L, Andrade R, Birgin EG, Martínez JM (2009) PACKMOL: a package for building initial configurations for molecular dynamics simulations. J Comput Chem 30:2157–2164. https://doi.org/10.1002/jcc.21224
Nagle JF (1993) Area/lipid of bilayers from NMR. Biophys J 64:1476–1481. https://doi.org/10.1016/S0006-3495(93)81514-5
Nagle JF, Tristan-Nagle S (2000) Structure of lipid bilayers. Biochim Biophys Acta 1469:159–195. https://doi.org/10.1016/s0304-4157(00)00016-2
Ortiz A, Teruel JA, Espuny MJ, Marqués A, Manresa Á, Aranda FJ (2008) Interactions of a Rhodococcus sp. biosurfactant trehalose lipid with phosphatidylethanolamine membranes. Biochim Biophys Acta—Biomembr 1778:2806–2813. https://doi.org/10.1016/j.bbamem.2008.07.016
Pabst G (2006) Global properties of biomimetic membranes: perspectives on molecular features. Biophys Rev Lett 1:57–84. https://doi.org/10.1142/s1793048006000069
Pabst G, Rappolt M, Amenitsch H, Laggner P (2000) Structural information from multilamellar liposomes at full hydration: full q-range fitting with high quality X-ray data. Phys Rev E—Stat Phys, Plasmas, Fluids, Relat Interdiscip Top 62:4000–4009. https://doi.org/10.1103/PhysRevE.62.4000
Pabst G, Koschuch R, Pozo-Navas B, Rappolt M, Lohner K, Laggner P (2003) Structural analysis of weakly ordered membrane stacks. J Appl Crystallogr 36:1378–1388. https://doi.org/10.1107/S0021889803017527
Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 52:7182–7190. https://doi.org/10.1063/1.328693
Pasenkiewicz-Gierula M, Takaoka Y, Miyagawa H, Kitamura K, Kusumi A (1997) Hydrogen bonding of water to phosphatidylcholine in the membrane as studied by a molecular dynamics simulation: location, geometry, and lipid-lipid bridging via hydrogen-bonded water. J Phys Chem 101:3677–3691. https://doi.org/10.1021/jp962099v
Picard M, Castells MC (2015) Re-visiting hypersensitivity reactions to taxanes: a comprehensive review. Clin Rev Allergy Immunol 49:177–191. https://doi.org/10.1007/s12016-014-8416-0
Quiox E, Lebeau B, Depierre A, Ducolone A, Moro-Sibilot D, Milleron B, Breton JL, Lemarie E, Pujol JL, Brechot JM, Zalcman G, Debieuvre D, Vaylet F, Vergnenegre A, Clouet P (2004) Randomised, multicentre phase II study assessing two doses of docetaxel (75 or 100 mg/m2) as second-line monotherapy for non-small-cell lung cancer. Ann Oncol 15:38–44. https://doi.org/10.1093/annonc/mdh005
Rowinsky EK (1997) The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 48:353–374. https://doi.org/10.1146/annurev.med.48.1.353
Saloustros E, Malamos E, Boukovinas I et al (2014) Dose-dense paclitaxel versus docetaxel following FEC as adjuvant chemotherapy in axillary node-positive early breast cancer: a multicenter randomized study of the hellenic oncology research group (HORG). Breast Cancer Res Treat 148:591–597. https://doi.org/10.1007/s10549-014-3202-5
Sarpietro M, Accolla M, Celia C, Grattoni A, Castelli F, Fresta M, Ferrari M, Paolino D (2013) Differential scanning calorimetry as a tool to investigate the transfer of anticancer drugs to biomembrane model. Curr Drug Targets 14:1053–1060. https://doi.org/10.2174/1389450111314090013
Schindler H, Seelig J (1975) Deuterium order parameters in relation to thermodynamic properties of a phospholipid bilayer. Stat Mech Interpret Biochem 14:2283–2287. https://doi.org/10.1021/bi00682a001
Schrödinger L (2010) The PyMOL molecular graphics system, Version 2.3
Seguin C, Kovacevich N, Voutsadakis IA (2017) Docetaxel-associated myalgia-arthralgia syndrome in patients with breast cancer. Breast Cancer Targets Ther 9:39–44. https://doi.org/10.2147/BCTT.S124646
Silva C, Aranda FJ, Ortiz A, Martínez V, Carvajal M, Teruel JA (2011) Molecular aspects of the interaction between plants sterols and DPPC bilayers. An experimental and theoretical approach. J Colloid Interface Sci 358:192–201. https://doi.org/10.1016/j.jcis.2011.02.048
Tan Q, Liu X, Fu X, Li Q, Dou J, Zhai G (2012) Current development in nanoformulations of docetaxel. Expert Opin Drug Deliv 9:975–990. https://doi.org/10.1517/17425247.2012.696606
Tardieu A, Luzzati V, Reman FC (1973) Structure and polymorphism of the hydrocarbon chains of lipids: a study of lecithin-water phases. J Mol Biol 75:711–733. https://doi.org/10.1016/0022-2836(73)90303-3
Trebunova M, Laputkova G, Slaba E, Laciakova K, Verebova A (2012) Effects of docetaxel, doxorubicin and cyclophosphamide on human breast cancer cell line MCF-7. Anticancer Res 32:2849–2854
Tyler AII, Law RV, Seddom JM (2015) X-ray diffraction of lipid model membranes. In: Owen DM (ed) Methods in membrane lipids methods in molecular biology (methods and protocols). Humana Press, New York, pp 99–225. https://doi.org/10.1007/978-1-4939-1752-5_16
Uson Junior PLS, Santos VM, Bugano DDG, VictorRother ESET, Maluf FC (2019) Systematic review and meta-analysis of docetaxel perioperative chemotherapy regimens in gastric and esophagogastric tumors. Sci Rep 9:1–9. https://doi.org/10.1038/s41598-019-52334-y
Venable RM, Krämer A, Pastor RW (2019) Molecular dynamics simulations of membrane permeability. Chem Rev 119:5954–5997. https://doi.org/10.1021/acs.chemrev.8b00486
Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT (1971) Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93:2325–2327. https://doi.org/10.1021/ja00738a045
Zhang YP, Lewis RNAH, McElhaney RN (1997) Calorimetric and spectroscopic studies of the thermotropic phase behavior of the n-saturated 1,2-diacylphosphatidylglycerols. Biophys J 72:779–793. https://doi.org/10.1016/S0006-3495(97)78712-5
Zhao L, Feng SS (2004) Effects of lipid chain length on molecular interactions between paclitaxel and phospholipid within model biomembranes. J Colloid Interface Sci 274:5–68. https://doi.org/10.1016/j.jcis.2003.12.009
Zhao L, Feng SS (2005) Effects of lipid chain unsaturation and headgroup type on molecular interactions between paclitaxel and phospholipid within model biomembrane. J Colloid Interface Sci 285:326–335. https://doi.org/10.1016/j.jcis.2004.11.032
Zhao L, Feng SS, Go ML (2004) Investigation of molecular interactions between paclitaxel and DPPC by Langmuir film balance and differential scanning calorimetry. J Pharm Sci 93:86–98. https://doi.org/10.1002/jps.10523
Zhao L, Feng SS, Kocherginsky N, Kostetski I (2007) DSC and EPR investigations on effects of cholesterol component on molecular interactions between paclitaxel and phospholipid within lipid bilayer membrane. Int J Pharm 338:258–266. https://doi.org/10.1016/j.ijpharm.2007.01.045
Acknowledgements
FJA would like to thank Dr. G. Pabst (University of Graz, Austria) for sharing the GAP program for analysis of SAXD data.
Funding
Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing financial interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Aranda, E., Teruel, J.A., Ortiz, A. et al. Interaction of Docetaxel with Phosphatidylcholine Membranes: A Combined Experimental and Computational Study. J Membrane Biol 255, 277–291 (2022). https://doi.org/10.1007/s00232-022-00219-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00232-022-00219-z